glycyrrhetinic acid has been researched along with Cancer of Lung in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Konoshima, T; Nishino, H; Takasaki, M; Tokuda, H | 1 |
Kim, B; Kim, C; Kim, HJ; Kim, JE; Kim, JH; Kim, SH; Ko, HS; Sohn, EJ; Song, J | 1 |
2 other study(ies) available for glycyrrhetinic acid and Cancer of Lung
Article | Year |
---|---|
Cancer chemopreventive agents (antitumor-promoters) from Ajuga decumbens.
Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Agents, Phytogenic; Antiviral Agents; Carcinogens; Female; Glycerol; Herpesvirus 4, Human; Lung Neoplasms; Mice; Mice, Inbred ICR; Papilloma; Plants, Medicinal; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1999 |
Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Activation; Glycyrrhetinic Acid; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; Molecular Conformation; Protein Kinase C beta; Protein Kinase C-alpha; Protein Kinase Inhibitors; Structure-Activity Relationship | 2014 |